Up to €500,000 for Healthcare Startups – EIT Health Transformative Healthcare Instrument

The Transformative Healthcare Instrument (THI) from EIT Health provides €300,000–€500,000 to high-potential European healthcare SMEs developing innovations in biotech, medtech, digital health, AI, biomarkers and diagnostics. The funding is designed to accelerate product development, commercialisation and preparation for future fundraising.

Here’s what you can expect:

• €300,000–€500,000 in funding per project

• EIT Health covers a maximum of 50% of total project costs

• Applicants must secure the remaining 50% as co-funding

• Support for product development and commercialisation

• Focus on solutions addressing unmet clinical needs

• Funding can help companies progress towards their next fundraising stage

• Eligible innovations include biotech, medtech, digital health, AI and biomarkers/diagnostics.

Who can apply?

• Private micro, small and medium-sized companies (SMEs)

• At least 4 full-time equivalent employees

• Applicants must have secured at least €2 million in equity investment during the previous 36 months

• That investment must include at least one new investor

• Biotech solutions must be at IML 5+

• Medtech solutions must be at IML 6+

• Digital health solutions must be at IML 7+

• Biomarker/diagnostic solutions must be at IML 7+.

Application deadline: 16 September 2026.